The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats

Myocardial fibrosis is a multistep process, which results in collagen deposition in the injured muscle. Empagliflozin, a sodium-glucose cotransporter 2 inhibitor (SGLT2i), decreases cardiovascular events risk....

Source: Cardiovascular Diabetology - July 2, 2021 Category: Cardiology Authors: Elias Daud, Offir Ertracht, Nadav Bandel, Gassan Moady, Monah Shehadeh, Tali Reuveni and Shaul Atar Tags: Original investigation Source Type: research